- Report
- August 2024
- 240 Pages
Global
From €4504EUR$4,949USD£3,861GBP
- Report
- May 2024
- 160 Pages
Global
From €4522EUR$4,969USD£3,877GBP
- Report
- December 2024
- 200 Pages
Global
From €3413EUR$3,750USD£2,926GBP
- Report
- May 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- May 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- June 2024
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- April 2025
- 184 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- December 2024
- 200 Pages
Global
From €3413EUR$3,750USD£2,926GBP
- Clinical Trials
- April 2024
- 1797 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- June 2024
- 90 Pages
United States
From €3185EUR$3,500USD£2,731GBP
- Report
- February 2024
- 213 Pages
Global
From €5252EUR$5,972USD£4,350GBP
- Report
- October 2023
- 159 Pages
Global
From €2139EUR$2,350USD£1,834GBP
- Report
- February 2023
- 100 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- March 2022
- 300 Pages
Global
From €3640EUR$4,000USD£3,121GBP
- Report
- September 2021
- 40 Pages
China
From €2366EUR$2,600USD£2,029GBP
- Report
- November 2023
- 139 Pages
Global
From €4050EUR$4,450USD£3,472GBP
- Report
- August 2022
- 117 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- June 2023
- 159 Pages
Global
From €6826EUR$7,500USD£5,852GBP
- Report
- September 2022
- 30 Pages
Global
From €2503EUR$2,750USD£2,146GBP
- Report
- January 2022
- 60 Pages
Global
From €3595EUR$3,950USD£3,082GBP

The Epilepsy Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Epilepsy drugs are used to treat seizures, which are caused by abnormal electrical activity in the brain. These drugs work by either suppressing the abnormal electrical activity or increasing the amount of neurotransmitters in the brain. Commonly used epilepsy drugs include anticonvulsants, benzodiazepines, and barbiturates.
Epilepsy drugs are used to treat a wide range of seizure types, including tonic-clonic seizures, absence seizures, and myoclonic seizures. They are also used to treat other neurological disorders, such as bipolar disorder and anxiety. The market for epilepsy drugs is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Show Less Read more